rs181216956
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_006949.4(STXBP2):c.497C>T(p.Thr166Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000233 in 1,551,858 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006949.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STXBP2 | NM_006949.4 | c.497C>T | p.Thr166Met | missense_variant | 7/19 | ENST00000221283.10 | NP_008880.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STXBP2 | ENST00000221283.10 | c.497C>T | p.Thr166Met | missense_variant | 7/19 | 1 | NM_006949.4 | ENSP00000221283.4 | ||
ENSG00000268400 | ENST00000698368.1 | n.*600C>T | non_coding_transcript_exon_variant | 9/20 | ENSP00000513686.1 | |||||
ENSG00000268400 | ENST00000698368.1 | n.*600C>T | 3_prime_UTR_variant | 9/20 | ENSP00000513686.1 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00115 AC: 180AN: 157034Hom.: 1 AF XY: 0.00124 AC XY: 103AN XY: 82790
GnomAD4 exome AF: 0.000216 AC: 302AN: 1399534Hom.: 1 Cov.: 32 AF XY: 0.000220 AC XY: 152AN XY: 690444
GnomAD4 genome AF: 0.000394 AC: 60AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 28, 2023 | Variant summary: STXBP2 c.497C>T (p.Thr166Met) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0011 in 157034 control chromosomes, predominantly at a frequency of 0.016 within the East Asian subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 7-fold of the estimated maximal expected allele frequency for a pathogenic variant in STXBP2 causing Familial Hemophagocytic Lymphohistiocytosis phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.497C>T has been reported in the literature in East Asian individuals affected with Familial Hemophagocytic Lymphohistiocytosis (e.g. Chen_2016, Miao_2019, Zhang_2019, Zhang_2020, Xu_2022), however most reported individuals carried the variant in monoallelic form, and some authors also noted that the frequency of the variant was similar to that found in ethinically matched controls (e.g. Miao_2019). These reports do not provide unequivocal conclusions about association of the variant with Familial Hemophagocytic Lymphohistiocytosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27209435, 30899265, 31388699, 32375849, 35296096). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 12, 2015 | - - |
Familial hemophagocytic lymphohistiocytosis 5 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at